Dear Editor,Myocardial infarction(MI)is one of the leading causes of cardiovascular-related mortality worldwide.Timely restoration of the blood supply to ischemic my-ocardium by thrombolysis or percuta-neous coronary ...Dear Editor,Myocardial infarction(MI)is one of the leading causes of cardiovascular-related mortality worldwide.Timely restoration of the blood supply to ischemic my-ocardium by thrombolysis or percuta-neous coronary intervention is a com-mon clinical practice and decreases the mortality risk for MI patients(Heusch,2020).展开更多
基金supported by the National Key R&D Program of China (2022YFB3605500 and 2022YFB3605503)the National Natural Science Foundation of China (62074039 and 12004074)+1 种基金China Postdoctoral Science Foundation (2020M681141)the National Postdoctoral Program for Innovative Talents (BX20190070)。
基金supported by grants from the National Key R&D Program of China(2018YFA0800501,2019YFA0801602)the National Natural Science Foundation of China(32230032,31730061,31430059,81870198)and Synogen Biopharma Co.,Nanjing,China.
文摘Dear Editor,Myocardial infarction(MI)is one of the leading causes of cardiovascular-related mortality worldwide.Timely restoration of the blood supply to ischemic my-ocardium by thrombolysis or percuta-neous coronary intervention is a com-mon clinical practice and decreases the mortality risk for MI patients(Heusch,2020).
